Johnson & Johnson Articles

Headlines 25 years ago this week....

5 June 2006

UK anger over NICE ruling on Alzheimer

5 June 2006

US FDA approves Alza's IONSYS

29 May 2006

Eisai achieves income growth of 14.2% to 63.4 billion yen in 2005; sales up 12.8%

29 May 2006

Ortho-McNeil sued over death of patient using Evra patch

29 May 2006

US patient assistance programs under review

29 May 2006

Daichii Sankyo's 2005/6 net income up 9.7%

22 May 2006

J-C submits paliperidone MAA to EMEA

15 May 2006

Millennium's 1st-qtr 2006 loss narrows 43%

15 May 2006

Stock Commentary - New York week to May 1, 2006

8 May 2006

Calls for postmarket trials resisted as GAO slams USA

1 May 2006

Ortho Biotech's Procrit: "current labeling best"

1 May 2006

Germany's GPC Biotech creates three senior positions in USA

24 April 2006

Enrollment continues in Voyager's Ph III AD trial

24 April 2006

J&J's 1st-qtr 2006 earnings up 16.4%, but sales weak

24 April 2006

DPI signs merger deal with Inifinity

24 April 2006

Janssen Pharma has grown in double-digits in Japan for seven consecutive years

10 April 2006

Eli Lilly comments on data from the CATIE PhII atypical antipsychotic drug study

10 April 2006

Biovail's 2005 revenue reaches $936M

3 April 2006

J&J still under probe

3 April 2006

Medtronic wins stent patent arbitration

3 April 2006

US FDA delays approval of Cephalon's Sparlon, firm cuts 2006 sales projections

3 April 2006

J&J completes $518M buy of Animas

27 February 2006

Qiagen reports strong 4th-qtr and fiscal 2005 year-end results

27 February 2006

US FDA urged to warn on ADHD drugs

20 February 2006

Stock Commentary - New York week to Feb 13, 2006

20 February 2006

Strong results for Boston Sci's Taxus

20 February 2006

UK AD treatment "lags behind" Europe, NICE urged to reconsider drugs policy

20 February 2006

Japan stock market week to Feb 6, 2006

13 February 2006

Pfizer considers selling consumer unit

13 February 2006

Akzo 2005 income rises 1.7%, Organon gains

13 February 2006

Stock Commentary - New York week to Jan 30

6 February 2006

Ionsys gains EU marketing go-ahead

6 February 2006

USA's IOM reviews drug safety

6 February 2006

Pharma/biotech mergers and acquisitions during 2005

6 February 2006

Animas merger with J&J subsidiary receives approval

6 February 2006

Abbott:13.4% 4th-qtr 2005 EPS growth, as expected

6 February 2006

J&J's 4th-qtr 2005 sales drop 1.1% on low Rx

30 January 2006

FDA close to approving GSK/Roche's number one obesity drug, Xenical, for OTC use

30 January 2006

UPDATE: UK policy change on Alzheimer's disease drugs meets with mixed response

30 January 2006

First EU biogenerics "possible in 2006, but USA faces long and winding road:" study

30 January 2006

Mylan received FDA OK for generic Aciphex

30 January 2006

J&J sweetens its offer for Guidant in face of Boston offer

16 January 2006

Boston Scientific reports 4th-qtr sales downturn

16 January 2006

Boston Scientific makes firm $25B offer for Guidant, but J&J confident of its deal

16 January 2006

Bayer and J&J honored in US Presidential award

16 January 2006

Round-up of pharmaceutical mergers and acquisitions during 2001

9 January 2006

J&J's Scios reports new Natrecor deaths

9 January 2006

Quetiapine efficacy equal to risperidone

9 January 2006

Japanese and Indian M&As feature in 2005 pharma/biotech deals

9 January 2006

Basilsea reports positive data from ceftobiprole trials

9 January 2006

Tibotec's HIV drug TMC125 effective in Ph IIb trials

9 January 2006

PharmaMar reports progress for Yondelis in soft tissue sarcoma

9 January 2006

Upbeat presentation on Bayer's R&D as firm raises forecast for drug candidates

19 December 2005

Editor's views on patients paying for medical care; Boston bid for Guidant

12 December 2005

Boston Scientific throws $25B spanner in the works of J&J's bid for Guidant

12 December 2005

FDA receives NDA for J&J paliperidone

12 December 2005

ALZA resubmits NDA for Ionsys

5 December 2005

Stent study shows no significant differences in safety or efficacy

5 December 2005

MorphoSys starts new Ab program with Centocor

12 September 2005

Novartis among global brand leaders

12 September 2005

Cordis announces positive Cypher stent data

12 September 2005

McNeil to co-promote modafinil for ADHD with Cephalon

5 September 2005

EU Commission clears J&J's takeover of Guidant

5 September 2005

Better-than-expected 1st qtr for Daiichi

22 August 2005

Arena gets EU patent supporting Ortho deal

22 August 2005

Zeltia to invest 155M euros in biotech units

15 August 2005

Cilag gains European nesiritide rights

8 August 2005

1st-half revenues fall 8% at Zeltia

8 August 2005

Scios subpoenaed over Natrecor

1 August 2005

J&J becomes "Official Partner" for 2008 and other Olympics

1 August 2005

Akzo Nobel net up 22% on 6% sales growth

25 July 2005

Johnson & Johnson beats consensus with 2nd-qtr sales up 11% and EPS growing to $0.93

25 July 2005

UK NICE seeks more evidence on AD drugs; action group formed to demand access

25 July 2005

US Senate views J&J's Propulsid promo

18 July 2005

Stock Commentary - New York

11 July 2005

Boston wins patent infringement suit with J&J

11 July 2005

Paradigm signs R&D accord with J&J

11 July 2005

J&J completes Peninsula Pharma acquisition

11 July 2005

Perrigo gets US marketing approval for generic Motrin

4 July 2005

Strong animal data for Callisto's Atipromod

4 July 2005

Does Japan change? - pharma executive mobility, restructuring by P Reed Maurer

4 July 2005

US court rules that Boston Sci infringed J&J stent patents

27 June 2005

S-P/Centocor's Remicade shows good results in PA

27 June 2005

Gen-Probe promotes Larry Mimms and Martin Edelshain

20 June 2005

Compugen and Ortho-Clinical enter diagnostic biomarker R&D accord

13 June 2005

Kosan's KOS-953: Ph I anticancer promise

13 June 2005

Kosan's KOS-953: Ph I anticancer promise

13 June 2005

Carl Icahn restates $20/share Mylan bid

13 June 2005

Premature ejaculation: pharma's next great unmet need

13 June 2005

Johnson & Johnson expects to have 10-13 NDAs cleared by 2007

6 June 2005

FDA accepts Remicade for priority review

6 June 2005

UK's NICE decision on Alzheimer's drugs meets unprecedented opposition

6 June 2005

GSK to bid for Boots Healthcare

30 May 2005

The FDA has rejected Johnson & Johnson's Risperdal for autism

30 May 2005

Top pharma firms failing to deliver major new products, says Wood Mackenzie

30 May 2005

Positive results on PharmaMar's Yondelis

23 May 2005

Daiichi FY2005 net income soars 39%

16 May 2005

S-P names Theo Niewenhuis VP, Remicade marketing

9 May 2005

Japan stock market week to May 2

9 May 2005

Showing 801-900 of 1988 articles

Go to beginningPreviousNextGo to end